Needham Reiterates Buy on Merit Medical Systems, Maintains $101 Price Target

Needham analyst Mike Matson has reiterated a Buy rating on Merit Medical Systems (NASDAQ: MMSI) and has maintained a price target of $101 for the stock. This endorsement reflects confidence in the company's performance and potential for growth.